IDPC reflects the network's collective efforts toward a world where responses to drug use, cultivation, production and supply are shaped by well-being, solidarity, evidence and compassion.
PRI offer guidance to support policy makers and practitioners in involving people with lived experience of the criminal justice system in reform efforts.
IDPC highlights growing tensions at the latest CND session, where geopolitical divides and challenges to the punitive drug control paradigm were prominent and potentiated by civil society.
C-EHRN provides an overview of the state of the art on safer use sites, exploring developments, challenges and needs, as well as recommendations and examples of good practice.
The New Zealand Drug Foundation calls for increased funding for a health-based approach to drug use that emphasises support, legal reform and Māori inclusion.
GI-TOC sheds light on the contents of 'kush' samples (which include synthetic cannabinoids and nitazenes), potential supply routes and health responses.
C-EHRN's provides an overview of the characteristics, capacities, and services of drug consumption rooms in Europe, highlighting recent developments and client profiles.
WHRIN and Talking Drugs highlight the importance of gender-specific ketamine harm reduction, calling for development of tailored services, collaboration with support programs for women and gender-diverse people and further research into ketamine's varied effects.
Olsen et al. celebrate the profound impact of Byrne's advocacy and lived experience on global drug policy and harm reduction, in this special section of the Drug and Alcohol Review.
